Department of Sports Medicine, Prevention and Rehabilitation Paracelsus Medical University
Salzburg, 5020, Austria
NCT Number: NCT02303379
It is the aim of our study to compare the effects of 6 and/or 2 years of either HIT (carried out at correctly assessed 85-95% of maximal heart rate), pyramid, or continuous endurance training, on changes of physical exercise capacity in cardiac patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Salzburg, 5020, Austria
The three exercise arms (isocaloric) are composed as follows:
Endurance training: 31 min at 65-75% HRmax, making it a total of 25min; HIT: 4x4min intervals at 85-95% HRmax divided by 3x3min of active recovery at 60-70% HRmax, making it a total of 25 min; Pyramid: One pyramid consists of 8 one-minute blocks. Those are grouped starting with one block of 70-75% HRmax, followed by one block at 75-80% HRmax and another one at 80-85% HRmax. The top of the pyramid are 2 blocks of 85-90% HRmax. Intensity is lowered afterwards with one block of 80-85% HRmax, followed by one block at 75-80% HRmax and last one at 70-75% HRmax. Two more pyramids follow, each divided by 2min of active recovery at 65-70% HRmax, making it a total of 28min.
All protocols are initiated by 5min of warm-up and end with 5min of cool-down, both at 60-70% HRmax.
Primary Outcome: Individual maximum power output in watt (Pmax). Secondary Outcome: Change of power output in watt at lactate tresholds at 2 and 4mmol/l.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Endurance training with constant work load 31min at 65-75% Hrmax
One pyramid consists of 8 one-minute blocks. Those are grouped starting with one block of 70-75% HRmax, followed by one block at 75-80% HRmax and another one at 80-85% HRmax. The top of the pyramid are 2 blocks of 85-90% HRmax. Intensity is lowered afterwards with one block of 80-85% HRmax, followed by one block at 75-80% HRmax and last one at 70-75% HRmax. Two more pyramids follow, each divided by 2min of active recovery at 65-70% HRmax, making it a total of 28min.
HIT: 4x4 min intervals at85-95% HRmax divided by 3x3min of active recovery at 60-70% HRmax, making it a total of 25min.
Time frame: 6 weeks or 36 weeks
PWC will be measured by graded exercise testing on cycle ergometer.
Time frame: 6 weeks or 36 weeks
Heart rate will be measured by graded exercise testing on cycle ergometer.
Time frame: 6 weeks or 36 weeks
Blood pressure will be measured by graded exercise testing on cycle ergometer.
Time frame: 6 weeks or 36 weeks
Lactate thresholds will be measured by graded exercise testing on cycle ergometer.
Time frame: 6 weeks or 36 weeks
Blood will be taken before and after intervention
Time frame: 6 weeks or 36 weeks
BMI will be taken before and after intervention
Time frame: 6 weeks or 36 weeks
Gene expression will be taken before and after intervention
Time frame: 6 weeks or 36 weeks
Quality of Life will be taken before and after intervention
Paracelsus Medical University
Other
Effects of Different Endurance Training Protocols on Physical Performance in Cardiac Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial DetailsNCT07468955
Arterial Occlusive Diseases, Arteriosclerosis
Kütahya, Center, Turkey (Türkiye)
View Trial DetailsNCT06029517
Arterial Occlusive Diseases, Arteriosclerosis
Buffalo, New York, United States
View Trial DetailsNCT04058990
Arterial Occlusive Diseases, Arteriosclerosis
Kitakyushu, Fukuoka, Japan
View Trial Details